Guizhou Xinbang Pharmaceutical Co Ltd (002390) — Cash Flow-to-Debt Ratio
Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a Cash Flow-to-Debt Ratio of 0.14x as of September 2025, meaning its operating cash flow of CN¥234.19 Million could theoretically repay 0% of its total liabilities (CN¥1.62 Billion) in one year. See Guizhou Xinbang Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guizhou Xinbang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Guizhou Xinbang Pharmaceutical Co Ltd across 19 annual periods. Also explore Guizhou Xinbang Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
Year-by-year debt coverage analysis for Guizhou Xinbang Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is Guizhou Xinbang Pharmaceutical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥634.97 Million | CN¥2.01 Billion | ▼ -15.9% |
| 2023 | 0.38x | CN¥790.62 Million | CN¥2.10 Billion | ▲ +73.6% |
| 2022 | 0.22x | CN¥590.80 Million | CN¥2.73 Billion | ▲ +32.4% |
| 2021 | 0.16x | CN¥457.97 Million | CN¥2.80 Billion | ▼ -1.0% |
| 2020 | 0.17x | CN¥742.11 Million | CN¥4.49 Billion | ▲ +0.1% |
| 2019 | 0.17x | CN¥886.33 Million | CN¥5.37 Billion | ▲ +529.3% |
| 2018 | -0.04x | CN¥-218.56 Million | CN¥5.69 Billion | ▼ -199.0% |
| 2017 | 0.04x | CN¥201.74 Million | CN¥5.20 Billion | ▲ +184.3% |
| 2016 | -0.05x | CN¥-198.59 Million | CN¥4.31 Billion | ▼ -181.3% |
| 2015 | 0.06x | CN¥217.40 Million | CN¥3.84 Billion | ▲ +178.9% |
| 2014 | -0.07x | CN¥-198.60 Million | CN¥2.77 Billion | ▼ -51.7% |
| 2013 | -0.05x | CN¥-21.34 Million | CN¥450.69 Million | ▲ +59.5% |
| 2012 | -0.12x | CN¥-36.46 Million | CN¥311.99 Million | ▲ +22.6% |
| 2011 | -0.15x | CN¥-39.87 Million | CN¥264.02 Million | ▼ -1101.1% |
| 2010 | 0.02x | CN¥2.50 Million | CN¥165.81 Million | ▼ -92.1% |
| 2009 | 0.19x | CN¥41.75 Million | CN¥217.51 Million | ▲ +81.5% |
| 2008 | 0.11x | CN¥24.86 Million | CN¥235.04 Million | ▼ -29.3% |
| 2007 | 0.15x | CN¥32.49 Million | CN¥216.99 Million | ▲ +379.3% |
| 2006 | 0.03x | CN¥7.35 Million | CN¥235.18 Million | — |